Coronavirus Vaccine Race: Novavax or Vaxart?

Neither Novavax (NASDAQ: NVAX) nor Vaxart (NASDAQ: VXRT) is at the head of the pack of drugmakers developing COVID-19 vaccine candidates. However, both stocks are way ahead of most of their rivals. Novavax shares are up close to 2,700% year to date; Vaxart stock has skyrocketed over 4,000% so far in 2020.

Which of these biotechs is more likely to win the coronavirus vaccine race? And which is the better overall pick for investors now? Here's how Novavax and Vaxart stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com